We recently reported that the ultralong protocol using a GnRH agonist for 3 months prior to IVF-ET improves the reproductive outcomes by reducing the detrimental effects of cytotoxic cytokines and oxidative stress in infertile women with endometriosis [22]. The gene discussed is GNRH1; the disease is endometriosis.